Viewing Study NCT07185893


Ignite Creation Date: 2025-12-25 @ 1:10 AM
Ignite Modification Date: 2026-07-20 @ 7:27 PM
Study NCT ID: NCT07185893
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-22
First Post: 2025-09-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors
Sponsor: Jun wang
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor Malignancies, Cancer View
None CTIT-Chemotherapy Induced Thrombocytopenia View
None Thrombocytopenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Romiplostim N01 View
None Human Interleukin-11 View
None solid tumor View
None thrombocytopenia View
None CTIT View